The U.S. cannabis industry continues evolving in 2025. Investors are watching major multi-state operators closely as legalization debates continue. Many traders remain cautious after repeated sector pullbacks. However, long-term growth expectations still look strong. Because of this, investors are searching for companies with real revenue, strong national footprints, and disciplined expansion plans.
Curaleaf Holdings, Inc. stands to benefit from the impending federal ban on hemp-derived THC, potentially reversing price compression and boosting margins. CURLF trades at a significant discount to peers, with EV/sales at 2.18x and price/sales at 1.37x, despite strong cash flow and margin performance. International growth remains robust, compounding at 56% YoY, offering long-term upside as new markets mature.
Marijuana stock investors are awaiting the next jump in the market. More people are readjusting their strategies to prepare for this upcoming trading year. There is another push for a chance to federally legalize cannabis. When the campaign begins, shareholders will take better market action. History has shown that when federal reform news shows progression, it reflects well in the public sector for most pot stocks.
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Boris Alexis Jordan CEO | OTCQX Exchange | CA23126M1023 ISIN |
| United States Country | 5,650 Employees | - Last Dividend | - Last Split | - IPO Date |
Curaleaf Holdings, Inc. stands as a prominent cannabis operator within the United States, encompassing its business operations into two main segments: Domestic Operations and International Operations. As a company, it is engaged in the cultivation, production, and sale of cannabis and related products, catering to both the retail and wholesale markets. With its headquarters based in New York, New York, Curaleaf has established itself as a key player in the industry, providing a wide range of cannabis products to a diverse clientele, while also spearheading initiatives in hemp-based product offerings and innovative cannabinoid applications.
Curaleaf offers an extensive selection of cannabis flower products, including pre-rolls for convenience, flower pots for personal use, and dry-herb vaporizer cartridges for a modern smoking experience. These products are designed to meet the varied preferences of consumers, offering high-quality cannabis strains cultivated under stringent standards.
The company provides a variety of concentrates specifically designed for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens. These products offer a discreet and efficient way to consume cannabis, with options available in different strains and potencies to cater to individual needs and preferences.
For consumers who prefer dabbing, Curaleaf presents a selection of concentrates including mints, distillate droppers, and more. These products allow for a potent and customizable cannabis experience, suitable for both seasoned consumers and those looking to explore concentrated forms of cannabis.
Beyond traditional cannabis products, Curaleaf has expanded its portfolio to include a variety of alternative formats such as mints, topical balms and lotions for external use, tinctures and lozenges for easy consumption, capsules for precise dosing, and a wide range of edibles. These products are designed to offer consumers diverse ways to experience the benefits of cannabis, with a focus on convenience, discretion, and efficacy.
Curaleaf also engages in the production and sale of hemp-based products and cannabinoids like cannabidiol (CBD) and cannabigerol (CBG). These offerings cater to the growing demand for non-psychoactive cannabinoids, known for their therapeutic benefits, and are available in various formulations to meet consumer needs in wellness and medicinal contexts.